From: Controlled Substance Agreements for Opioids in a Primary Care Practice
Condition (n (%)) | |
---|---|
Musculoskeletal pain | 721 (67.6) |
Chronic pain syndrome | 156 (14.6) |
Neuropathy | 91 (8.5) |
Headache/Migraine | 45 (4.2) |
Abdominal pain | 11 (1.0) |
Cutaneous/subcutaneous | 10 (0.9) |
Colorectal disease | 8 (0.8) |
Autoimmune disease | 7 (0.7) |
Nephrolithiasis | 3 (0.3) |
Sleep disorder | 3 (0.3) |
Autonomic dysfunction | 2 (0.2) |
Multiple sclerosis | 2 (0.2) |
Sarcoidosis | 2 (0.2) |
Syringomyelia | 2 (0.2) |
Angina | 1 (0.1) |
Dyspnea | 1 (0.1) |
Lymphedema | 1 (0.1) |
Age-Weighted Charlson Index (Mean (SD)) | 3.9 (3.1) |
Pain (Mean (SD), N = 860) | |
Current | 4.2 (2.5) |
Average | 5.4 (2.1) |
Worst | 7.6 (2.1) |
Moderate to Severe Anxiety Diagnosis (GAD-7 ≥ 10), N (%), N = 578 | 83 (7.8) |
Moderate to Moderately Severe Depression Diagnosis (PHQ-9 ≥ 10), N (%), N = 785 | 121 (11.4) |